autologus dendritic cell therapy (PT. Prodia Stem Cell)

N/A

Report date: 2025/03/14 16:39:19

Base Information

Drug Nameautologus dendritic cell therapy (PT. Prodia Stem Cell)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNasopharyngeal Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndonesia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPt. Prodia Stem Cell Indonesia
China Registration ClassN/A

Develop Information

Active CompaniesPt. Prodia Stem Cell Indonesia
Inactive CompaniesN/A
Active IndicationsNasopharyngeal Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A